CDMOs Step Up Parenteral Manufacturing Support

Throughout the pandemic, CDMOs of all sizes and capabilities stepped in to fulfil industry needs, providing the capabilities and capacities for the manufacture of essential medicines.

EXECUTIVE INTERVIEW: Broadening Our Biologics Footprint, Together

At the end of 2021, PCI Pharma Services acquired Lyophilization Services of New England, Inc. (LSNE), expanding PCI’s breadth of services as a global CDMO, building on its expertise in specialty manufacturing and packaging at both clinical and ...

Solid-Dose Packaging Trends

Solid-dosage forms continue to play an essential role in the pharmaceutical marketplace despite the attention the COVID-19 pandemic has focused on parenteral products.

Vaccinating the Globe: Choosing the right CDMO Partner.

The year is 2030, a new variant of the latest virus-X is highly contagious and circulating globally. Alexa has just notified you that your custom-made vaccine strips have been dispatched and will arrive today between 9 and 9:15 a.m.

Outsourcing Biologics: Key Considerations

Biologics are a more complex class of pharmaceuticals to manufacture, package, store and distribute than their chemical counterparts.

HPAPI Manufacturing – Choosing The Right CDMO

Safe handling of highly potent molecules is complex, and the associated regulatory requirements are growing. As a result, pharmaceutical companies recognize the importance of selecting the right partner for the development.

The trusted partner for global integrated CDMO services.

When it comes to pharmaceutical and biopharmaceutical supply chain expertise who do you trust?

Start your PCI experience today.

Your bridge between life-changing therapies and patients.